{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T20:28:20Z","timestamp":1783628900486,"version":"3.55.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.medcli.2026.107455","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T21:21:51Z","timestamp":1778880111000},"page":"107455","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Valor de la biopsia renal en los pacientes con disfunci\u00f3n renal y ANCA positivos con especificidad anti-MPO y anti-PR3"],"prefix":"10.1016","volume":"166","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0588-2415","authenticated-orcid":false,"given":"Sergio","family":"Barroso Hern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Matallana Encinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"Romero Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Guerrero Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Inmaculada","family":"Alcal\u00e1 Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge Alberto","family":"Rodr\u00edguez Sabill\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"\u00c1lvarez L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isis","family":"Cerezo Arias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00e1s Roberto","family":"Robles-P\u00e9rez Monteoliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2026.107455_bib0150","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.2215\/CJN.02500317","article-title":"ANCA Glomerulonephritis and Vasculitis","volume":"12","author":"Jennette","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.medcli.2026.107455_bib0155","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41584-022-00819-y","article-title":"Genetics of ANCA-associated vasculitis: Role in pathogenesis, classification and management","volume":"18","author":"Trivioli","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.medcli.2026.107455_bib0160","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1136\/annrheumdis-2015-208073","article-title":"Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type","volume":"75","author":"Unizony","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.medcli.2026.107455_bib0165","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/nrrheum.2016.123","article-title":"ANCA-associated vasculitis-clinical utility of using ANCA specificity to classify patients","volume":"12","author":"Cornec","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.medcli.2026.107455_bib0170","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/1756-185X.13483","article-title":"Clinical significance of positive anti-neutrophil cytoplasmic antibodies without evidence of anti-neutrophil cytoplasmic antibodies-associated vasculitis","volume":"22","author":"Bornstein","year":"2019","journal-title":"Int J Rheum Dis"},{"issue":"Suppl 3","key":"10.1016\/j.medcli.2026.107455_bib0175","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/j.kint.2023.10.008","article-title":"KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)\u2013Associated Vasculitis","volume":"105","author":"Floege","year":"2024","journal-title":"Kidney Int"},{"issue":"Suppl 4","key":"10.1016\/j.medcli.2026.107455_bib0180","first-page":"S1","article-title":"Kidney disease: Improving global outcomes (KDIGO) glomerulonephritis work group KDIGO clinical practice guideline for glomerulonephritis","author":"Cattran","year":"2012","journal-title":"Kidney Int V 2"},{"key":"10.1016\/j.medcli.2026.107455_bib0185","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1681\/ASN.2013111233","article-title":"ANCA as a predictor of relapse: Useful in patients with renal involvement but not in patients with nonrenal disease","author":"Kemna","year":"2015","journal-title":"J Am Soc Nephrol V 26"},{"key":"10.1016\/j.medcli.2026.107455_bib0190","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1399-0012.2009.01010.x","article-title":"Two cases of ANCA-associated vasculitis in post-transplant kidney: Relapse and de novo","volume":"23","author":"Tabata","year":"2009","journal-title":"Clin Transplant I Suppl 20"},{"key":"10.1016\/j.medcli.2026.107455_bib0195","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/rheumatology\/ker280","article-title":"Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis-a meta-analysis","volume":"51","author":"Tomasson","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.medcli.2026.107455_bib0200","article-title":"Relationship Between C-Reactive Protein\/Serum Albumin Ratio Neutrophil\/Lymphocyte Ratio, and ANCA-Associated Vasculitis Activity: A Retrospective Single Center Cohort Study","volume":"9","author":"Tian","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.medcli.2026.107455_bib0205","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.kint.2017.03.014","article-title":"Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients","volume":"92","author":"McAdoo","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.medcli.2026.107455_bib0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102885","article-title":"ANCA and anti-glomerular basement membrane double-positive patients: A systematic review of the literature","volume":"20","author":"Philip","year":"2021","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.medcli.2026.107455_bib0215","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.kint.2023.02.029","article-title":"Proteinuria and hematuria after remission induction are associated with outcome in ANCA-associated vasculitis","volume":"103","author":"Benichou","year":"2023","journal-title":"Kidney Int"},{"key":"10.1016\/j.medcli.2026.107455_bib0220","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1159\/000500352","article-title":"Prognostic Value of Microscopic Hematuria after Induction of Remission in Antineutrophil Cytoplasmic Antibodies-Associated Vasculitis","volume":"49","author":"Vandenbussche","year":"2019","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.medcli.2026.107455_bib0225","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.3389\/fimmu.2019.02166","article-title":"Complement inhibitors in clinical trials for glomerular diseases","volume":"10","author":"Zipfel","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.medcli.2026.107455_bib0230","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1002\/art.41011","article-title":"Measuring Circulating Complement Activation Products in Myeloperoxidase\u2013 and Proteinase 3\u2013Antineutrophil Cytoplasmic Antibody\u2013Associated Vasculitis","volume":"71","author":"Wu","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.medcli.2026.107455_bib0235","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.semnephrol.2013.08.006","article-title":"Complement in ANCA-associated vasculitis","volume":"33","author":"Charles Jennette","year":"2013","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.medcli.2026.107455_bib0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158871","article-title":"Low serum complement C3 levels at diagnosis of renal ANCA-associated vasculitis is associated with poor prognosis","volume":"11","author":"Augusto","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.medcli.2026.107455_bib0245","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1007\/s10067-016-3384-9","article-title":"Circulating C3 levels predict renal and global outcome in patients with renal vasculitis","volume":"35","author":"Villacorta","year":"2016","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.medcli.2026.107455_bib0250","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1080\/0886022X.2022.2068445","article-title":"Circulating immune-complexes and complement activation through the classical pathway in myeloperoxidase-ANCA-associated glomerulonephritis","volume":"44","author":"Kojima","year":"2022","journal-title":"Ren Fail"},{"key":"10.1016\/j.medcli.2026.107455_bib0255","doi-asserted-by":"crossref","first-page":"14436","DOI":"10.3390\/ijms241914436","article-title":"Serum Complement C4 Levels Are a Useful Biomarker for Predicting End-Stage Renal Disease in Microscopic Polyangiitis","volume":"24","author":"Matsuda","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.medcli.2026.107455_bib0260","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1056\/NEJM197112302852701","article-title":"Effect of Cyclophosphamide upon the Immune Response in Wegener's Granulomatosis","volume":"285","author":"Fauci","year":"1971","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2026.107455_bib0265","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/ard-2022-223764","article-title":"EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update","volume":"83","author":"Hellmich","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.medcli.2026.107455_bib0270","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/ndt\/gfx378","article-title":"Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis","volume":"34","author":"Mcadoo","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.medcli.2026.107455_bib0275","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1136\/annrheumdis-2014-206404","article-title":"Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial","volume":"74","author":"Jones","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.medcli.2026.107455_bib0280","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1056\/NEJMoa1803537","article-title":"Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis","volume":"382","author":"Walsh","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2026.107455_bib0285","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.kint.2024.11.029","article-title":"The effects of plasma exchange and glucocorticoids on early kidney function among patients with ANCA-associated vasculitis in the PEXIVAS trial","volume":"107","author":"Odler","year":"2025","journal-title":"Kidney Int"},{"key":"10.1016\/j.medcli.2026.107455_bib0290","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.kint.2018.07.020","article-title":"Development and validation of a renal risk score in ANCA-associated glomerulonephritis","volume":"94","author":"Brix","year":"2018","journal-title":"Kidney Int"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775326001053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775326001053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T19:57:15Z","timestamp":1783627035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775326001053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0025775326001053"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2026.107455","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Valor de la biopsia renal en los pacientes con disfunci\u00f3n renal y ANCA positivos con especificidad anti-MPO y anti-PR3","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2026.107455","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107455"}}